SBFM has 36-month beta value of -1.02. Analysts have mixed views on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for SBFM is 2.00M, and currently, short sellers hold a 18.71% ratio of that float. The average trading volume of SBFM on November 22, 2024 was 169.28K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
SBFM) stock’s latest price update
The stock of Sunshine Biopharma Inc (NASDAQ: SBFM) has increased by 20.75 when compared to last closing price of 2.12.Despite this, the company has seen a gain of 9.16% in its stock price over the last five trading days. accesswire.com reported 2024-11-22 that FORT LAUDERDALE, FL / ACCESSWIRE / November 22, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the “Company”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that its wholly owned Canadian subsidiary, Nora Pharma Inc., has launched a new generic prescription drug. The newly launched drug is Ursodiol, a generic version of URSO DS®.
SBFM’s Market Performance
Sunshine Biopharma Inc (SBFM) has seen a 9.16% rise in stock performance for the week, with a -14.96% decline in the past month and a -12.63% plunge in the past quarter. The volatility ratio for the week is 8.03%, and the volatility levels for the past 30 days are at 6.03% for SBFM. The simple moving average for the past 20 days is -2.18% for SBFM’s stock, with a -93.55% simple moving average for the past 200 days.
SBFM Trading at -10.80% from the 50-Day Moving Average
After a stumble in the market that brought SBFM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.60% of loss for the given period.
Volatility was left at 6.03%, however, over the last 30 days, the volatility rate increased by 8.03%, as shares sank -16.56% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -10.00% lower at present.
During the last 5 trading sessions, SBFM rose by +7.46%, which changed the moving average for the period of 200-days by -99.45% in comparison to the 20-day moving average, which settled at $2.61. In addition, Sunshine Biopharma Inc saw -99.53% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SBFM starting from Slilaty Steve N., who purchase 100,000 shares at the price of $0.10 back on Mar 04 ’24. After this action, Slilaty Steve N. now owns 130,000 shares of Sunshine Biopharma Inc, valued at $10,000 using the latest closing price.
Slilaty Steve N., the Chief Executive Officer of Sunshine Biopharma Inc, purchase 20,000 shares at $0.10 during a trade that took place back on Feb 08 ’24, which means that Slilaty Steve N. is holding 30,000 shares at $2,000 based on the most recent closing price.
Stock Fundamentals for SBFM
Current profitability levels for the company are sitting at:
- -0.14 for the present operating margin
- 0.3 for the gross margin
The net margin for Sunshine Biopharma Inc stands at -0.13. The total capital return value is set at -0.18. Equity return is now at value -17.98, with -14.65 for asset returns.
Currently, EBITDA for the company is -3.82 million with net debt to EBITDA at 2.9. When we switch over and look at the enterprise to sales, we see a ratio of -0.2. The receivables turnover for the company is 10.24for trailing twelve months and the total asset turnover is 1.1. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.74.
Conclusion
To put it simply, Sunshine Biopharma Inc (SBFM) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
